Exciting news!🤩 Check out our recently published work on the role of ELTD-1 in vascular phenotype and immune infiltration in glioma🧠🔬! academic.oup.com/neuro-oncology… Kalyani Vemuri Tiarne van de Walle Mohan Luuk van Hooren @AnnaDimberg Uppsala Vascular Biology IGP_UU @UU_University

I hope that major journals will consider changing their EndNote styles to highlight all co-first authors. What should the next steps be to make a real change? || First authors: is co-equal genuinely equal? nature.com/articles/d4158…

New Research: Tertiary Lymphoid Structures in the Central Nervous System: Implications for Glioblastoma: Glioblastoma is the most common and aggressive brain tumor, which is uniformly lethal due to its extreme invasiveness and the absence of… frontiersin.org/articles/10.33… #immunology

Can tertiary lymphoid structures be good tools to fight brain cancer? 🧠Check out our newly published review for some insight!🧐frontiersin.org/articles/10.33… Tiarne van de Walle Alessandra Vaccaro Mohan @IlkkaPietil @AnnaDimberg Frontiers - Immunology

Curious about lymph node-like structures in the central nervous system? 🤔 What about their possible effects on brain cancer? 🧠 See our new review to learn more! frontiersin.org/articles/10.33…

We are proud to share the publication of our review: One Omics Approach Does Not Rule Them All: The Metabolome and the Epigenome Join Forces in Haematological Malignancies mdpi.com/1303392 Epigenomes MDPI @UU_University IGP_UU Helena J Wiklund Patrick Nylund, PhD Berta Garrido-Zabala

Exciting new work from @MagnusEssand’s group published in Nat Biomed Eng. reporting how arming CAR-T cells with neutrophil-activating protein (NAP) can improve their efficacy in solid tumors Congratulations @ChuanJin JingMa Mohan @DiYu 👏 nature.com/articles/s4155…

Exciting to share our #cartcell work.. #Immunotherapy #Science

Curious on how we modified blood vessels to boost immunity and treat brain cancer? 💉🧠 Our new publication is out now on Cancer Cell ! Big congrats to the first authors of this work, Mohan , Alessandra Vaccaro & Tiarne van de Walle , and to the whole team 🥳 cell.com/cancer-cell/fu…

Check out the latest publication from our group to learn about how targeting blood vessels can improve the immune response in glioma! Wonderful work by Mohan Alessandra Vaccaro Tiarne van de Walle et al.

DimbergLab Cancer Cell Mohan Alessandra Vaccaro Tiarne van de Walle Amazing paper & super promising therapeutic approach! Honored to have made a small contribution to this in the early days of the project. And the figures and videos are stunning, teaching material for immunology students!❤️ Congrats to all the co-authors on this achievement!! 👍

Online Now: Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma dlvr.it/Sp6vzN

Read this week's #ResearchWatch: AAV-Mediated Gene Delivery of LIGHT Prolongs Survival in #Glioblastoma, summarizing the work of Mohan, Alessandra Vaccaro, Tiarne van de Walle, Magnus Essand, DimbergLab et al. bit.ly/3q5eQLg @UU_University

Our recent work on AAV-mediated #Immunotherapy for #Glioblastoma is highlighted by Cancer Discovery.

Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma dlvr.it/SqZ6Kv

Read our latest article published in Nature Communications on how single chain fragments in CARs cause tonic signalling and affect CAR-T cell function. Congratulations to Essand Lab and Tina Sarèn. #Immuntherapie , #cartcells, #cancer, #cellthetapy, #genetherapy, #Tcells

I don't know if that's the only root cause of tonic signaling but great work by $ELIC researchers. Makes sense wrt $ACLX eg who don't use scFv's but D-Domains. Complementarity-determining region clustering may cause CAR-T cell dysfunction nature.com/articles/s4146…

Elicera Therapeutics publishes a scientific article in Nature Communications about the CAR T construct in the ELC-401 program | Elicera Therapeutics, #cartcell, #tcell, #glioma, #CancerResearch, #cancer #celltherapy, #Immunotherapy, IGP_UU, @UU_University. nature.com/articles/s4146…

Curious to know the clinical outcome of our study and how characteristics of the CAR-T infusion products may effect? Read our latest publication in Clinical Cancer Research ! Thank you to everyone involved in this work😍Essand Lab Mohan #immunotherapy #CARTcell aacrjournals.org/clincancerres/…

Read our recent publication in Clinical Cancer Research on how characteristics of #CARTcell infusion product influences treatment outcome in #lymphoma patients. Congratulations to authors Tina Sarèn , Essand Lab from @UU_University at IGP_UU